ProQR Therapeutics (PRQR) Net Income (QoQ) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.73% |
| Sep 30, 2025 | 4.86% |
| Jun 30, 2025 | -21.87% |
| Mar 31, 2025 | -5.61% |
| Dec 31, 2024 | -12.54% |
| Sep 30, 2024 | -146.91% |
| Jun 30, 2024 | 55.81% |
| Mar 31, 2024 | -30.08% |
| Dec 31, 2023 | 16.18% |
| Sep 30, 2023 | 16.14% |
| Jun 30, 2023 | 4.79% |
| Mar 31, 2023 | 20.73% |
| Dec 31, 2022 | 36.40% |
| Sep 30, 2022 | -18.31% |
| Jun 30, 2022 | 11.69% |
| Mar 31, 2022 | 3.50% |
| Dec 31, 2021 | -15.47% |
| Sep 30, 2021 | -7.97% |
| Jun 30, 2021 | -8.91% |
| Mar 31, 2021 | -4.95% |
| Dec 31, 2020 | -9.64% |
| Sep 30, 2020 | -242.93% |
| Jun 30, 2020 | 79.66% |
| Mar 31, 2020 | 5.67% |
| Dec 31, 2019 | -28.90% |
| Sep 30, 2019 | -12.51% |
| Jun 30, 2019 | 20.61% |
| Mar 31, 2019 | -14.22% |
| Dec 31, 2018 | -113.06% |
| Sep 30, 2018 | 24.78% |
| Jun 30, 2018 | -100.08% |
| Mar 31, 2018 | 95,805.22% |
| Dec 31, 2017 | -99.89% |
| Sep 30, 2017 | 101,445.33% |
| Jun 30, 2017 | -205.68% |
| Mar 31, 2017 | 195.63% |
| Dec 31, 2016 | -0.50% |
| Sep 30, 2016 | 8.26% |
| Jun 30, 2016 | -23.61% |
| Mar 31, 2016 | -17.67% |
| Dec 31, 2015 | -18.49% |
| Sep 30, 2015 | 2.30% |
| Jun 30, 2015 | 6.38% |
| Mar 31, 2015 | -22.91% |
| Dec 31, 2014 | 3.42% |
| Mar 31, 2014 | -15.71% |
| Dec 31, 2013 | -88.09% |